Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
Go back to Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors| (NASDAQ: ERAS) | Delayed: 14.96 -0.38 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.34 | 52 Week High | $ | |||
| Open | $15.41 | 52 Week Low | $ | |||
| Day High | $15.47 | P/E | N/A | |||
| Day Low | $14.51 | EPS | $ | |||
| Volume | 1,927,284 | |||||
